CrushSCI.com
83.7平均天数
70.5中位天数
16最短天数
205最长天数
2372025发文量

Paper Review Records

全部论文审稿周期

18 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

36 天

Uncovering non-thrombotic roles of platelets in sepsis pathophysiology

作者
Ema Hashiguchi; Takashi Ito展开收起
作者单位
1. Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan; 2. Department of Hematology and Immunology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan展开收起
PDF源文件 DOI 网页
22 天

Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms

作者
Tomohiro Yabushita; Susumu Goyama展开收起
作者单位
1. International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan; 2. Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 3. Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan展开收起
PDF源文件 DOI 网页
99 天

Current perspectives on high-risk genomic profiles in chronic myeloid leukemia: from bench to clinical practice

作者
Mohamed Isam Sharif; Agustina Maria Perusini; Hassan Sibai; Dennis Dong Hwan Kim展开收起
作者单位
1. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; 2. Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada展开收起
PDF源文件 DOI 网页
98 天

TP53 mutations and IGHV in naïve chronic lymphocytic leukemia: retrospective analysis of data from a Spanish collaborative network

作者
María José Terol; Alicia Serrano; Blanca Ferrer-Lores; Francesc Bosch; Marcos González; Marta Crespo; Miguel Alcoceba; Azahara Fuentes; Felipe Javier Chaves; Miguel Villanueva展开收起
作者单位
1. Department of Hematology, University Clinic Hospital of Valencia, INCLIVA (Health Research Institute), University of Valencia, Valencia, Spain; 2. Spanish CLL Study Group (GELLC), Madrid, Spain; 3. Hematology Service, Vall d’Hebron University Hospital, Barcelona, Spain; 4. Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC (CB16/12/00233) and Cancer Research Center -IBMCC (USAL-CSIC), Salamanca, Spain; 5. Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; 6. Experimental Hematology, Hebron Institute of Oncology (VHIO), Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Hebron Barcelona Hospital Campus, Barcelona, Spain; 7. Johnson and Johnson, Madrid, Spain展开收起
PDF源文件 DOI 网页
97 天

Temporal trends in transfusion-transmitted cytomegalovirus infection among cytomegalovirus-seronegative HSCT recipients

作者
Kimikazu Yakushijin; Takahiro Fukuda; Masao Ogata; Sachiko Seo; Ryu Yanagisawa; Michiko Kajiwara; Naoyuki Uchida; Youko Suehiro; Noriko Doki; Yoshinobu Kanda; Masatsugu Tanaka; Mineo Kurokawa; Daiichiro Hasegawa; Motoshi Ichikawa; Nobuhiro Tsukada; Yoshiyuki Takahashi; Satoshi Yoshihara; Satoshi Okada; Shinichi Ito; Shingo Yano; Makoto Onizuka; Fumihiko Ishimaru; Yoshiko Atsuta; Hideki Nakasone展开收起
作者单位
1. Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan; 2. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; 3. Department of Hematology, Oita University Hospital, Yufu, Japan; 4. Division of Hematology, Department of Internal Medicine, Tokyo Women’s Medical University, Tokyo, Japan; 5. Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan; 6. Center for Transfusion Medicine and Cell Therapy, Institute of Science Tokyo Hospital, Tokyo, Japan; 7. Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan; 8. Department of Hematology and Cell Therapy, NHO Kyushu Cancer Center, Fukuoka, Japan; 9. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; 10. Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; 11. Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; 12. Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan; 13. Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children’s Hospital, Kobe, Japan; 14. Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan; 15. Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan; 16. Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan; 17. Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan; 18. Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan; 19. Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan; 20. Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan; 21. Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan; 22. Japanese Red Cross Blood Service Headquarters, Tokyo, Japan; 23. Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; 24. Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; 25. Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan展开收起
PDF源文件 DOI 网页
40 天

Strategies to prevent post-transplant relapse in acute myeloid leukemia and myelodysplastic syndromes

作者
Yuho Najima展开收起
作者单位
1. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Japan展开收起
PDF源文件 DOI 网页

FAQ

INTERNATIONAL JOURNAL OF HEMATOLOGY审稿要多久?

截至2026-11-19,CrushSCI 收录了 INTERNATIONAL JOURNAL OF HEMATOLOGY 的 18 篇完整审稿记录。最快一篇从收稿到录用用了 16 天(Recent advances in the pathophysiology and treatment of GVHD,2026-04-05 收稿,2026-04-21 录用),最慢一篇用了 205 天;平均 83.7 天,中位数 70.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。